Mirza Mansoor Raza
SEC insider (Form 3/4/5 filer). CIK 0001588389. Director at SERA PROGNOSTICS, INC. (SERA) and 2 other issuers. 24 reported Form 4/5 transactions since Sep 2024; latest on Jul 10, 2026. Located in SALT LAKE CITY, UT.
Companies Mirza Mansoor Raza has filed insider reports for
- SERA PROGNOSTICS, INC. (SERA): Director
- Acrivon Therapeutics, Inc. (ACRV): Officer, Chief Medical Officer
- Karyopharm Therapeutics Inc. (KPTI): Director
Mirza Mansoor Raza
CIK: 0001588389
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Jul 10, 2026SERA
SERA PROGNOSTICS, INC.
AwardDirect22.4K shares- - Jul 10, 2026SERA
SERA PROGNOSTICS, INC.
AwardDirect1.8K shares- - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect38.8K shares- - Mar 1, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
174.1K shares- - Dec 5, 2025SERA
SERA PROGNOSTICS, INC.
SaleDirect292 shares at avg. $3.05$890.6 - Nov 5, 2025SERA
SERA PROGNOSTICS, INC.
SaleDirect221 shares at avg. $3.04$671.84 - Oct 6, 2025SERA
SERA PROGNOSTICS, INC.
SaleDirect227 shares at avg. $3.16$717.32 - Oct 1, 2025ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
225K shares- - Sep 5, 2025SERA
SERA PROGNOSTICS, INC.
SaleDirect222 shares at avg. $3.35$743.7 - Aug 5, 2025SERA
SERA PROGNOSTICS, INC.
SaleDirect225 shares at avg. $2.50$562.5
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 10, 2026 |  SERA SERA PROGNOSTICS, INC. | Award | 22,426 | - | $0 | Direct |
| Jul 10, 2026 | SERA SERA PROGNOSTICS, INC. | Award | 1,771 | - | $0 | Direct |
| May 18, 2026 |  ACRV Acrivon Therapeutics, Inc. | Award | 38,817 | - | $0 | Direct |
| Mar 1, 2026 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 174,068 | - | - | Direct |
| Dec 5, 2025 | SERA SERA PROGNOSTICS, INC. | Sale | 292 | $3.05 | $891 | Direct |
| Nov 5, 2025 | SERA SERA PROGNOSTICS, INC. | Sale | 221 | $3.04 | $672 | Direct |
| Oct 6, 2025 | SERA SERA PROGNOSTICS, INC. | Sale | 227 | $3.16 | $717 | Direct |
| Oct 1, 2025 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 225,000 | - | - | Direct |
| Sep 5, 2025 | SERA SERA PROGNOSTICS, INC. | Sale | 222 | $3.35 | $744 | Direct |
| Aug 5, 2025 | SERA SERA PROGNOSTICS, INC. | Sale | 225 | $2.50 | $563 | Direct |
1-10 of 24 transactions